United States · Series A startup
4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$23Mraised across 4 rounds since 2012, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $20M sold, first sale Oct 2012
Novartis Venture Fund
GBS Ventures
Venture Investors
State of Wisconsin Investment BoardFrom a historical funding recordSEC filing: $11M sold, first sale Oct 2012
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Oct 2012
No investor was named in the report.
From a historical funding recordSEC filing: $163K sold, first sale Mar 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Novartis Venture FundGBS VenturesVenture InvestorsState of Wisconsin Investment BoardH&Q Life Sciences InvestorsH&Q Healthcare InvestorsTimothy J. BarberichMissing a round, or an investor who was in one? Tell us.
Neurovance's investors include Novartis Venture Fund, GBS Ventures, Venture Investors, State of Wisconsin Investment Board and H&Q Life Sciences Investors, and 2 more on record.
Neurovance has raised $23M across 4 rounds since 2012.
Neurovance's most recent round was a Series A of $5.5M in Mar 2015.
Neurovance's largest round on record is $11M (Venture), in Oct 2012.
Neurovance's first round on record, in Apr 2014, was backed by Novartis Venture Fund, GBS Ventures and Venture Investors and 4 others.
Neurovance's latest named round is a Series A, in Mar 2015.
Neurovance is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·